Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PICSI vs. MACS for Abnormal Sperm DNA Fragmentation ICSI Cases: a Prospective Randomized Trial

NCT03398317 is registered in ClinicalTrials.gov with Ganin Fertility Center as lead sponsor.

NCT NCT03398317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03398317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PICSI vs. MACS for Abnormal Sperm DNA Fragmentation ICSI Cases: a Prospective Randomized Trial
Lead sponsor
Ganin Fertility Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2017
Completion date
March 30, 2019
Enrollment
396 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sperm dna fragmentation